Compare
Compare archived captures
This view highlights text differences between two archived captures. It does not interpret meaning or provide guidance.
Descriptive changes only
This comparison highlights text changes between archived captures. It does not interpret the change or provide medical advice. For up-to-date recommendations, always consult the official source website.
Need to cite this comparison? See /cite.
Earlier capture
Regulatory review of drugs and devices: Expanding priority review pathways for drugs that meet health care system needs - Canada.ca
Apr 18, 2025
legacy-hc-2025-04-21
ID 256152
Later capture
Regulatory review of drugs and devices: Expanding priority review pathways for drugs that meet health care system needs - Canada.ca
Jan 2, 2026
hc-20260101
ID 428613
updated2 sections changed
2 sections changed0 added0 removed+0 / -3 linesChange ratio: 8%
--- +++ @@ -1,6 +1,4 @@ Expanding priority review pathways for drugs that meet health care system needs-From:-Health Canada This project will build new review pathways for those drugs shown to meet health care system needs. The outcome for the people of Canada will be faster access to drugs, including drugs for rare diseases. The tasks for this project include:@@ -16,5 +14,4 @@ a draft policy and guidance document completed for broad consultation (fall 2018) We expect to start using these new pathways in 2019. Page details-Date modified: 2018-02-16